Pristine gelatin incorporation as a strategy to enhance the biofunctionality of poly(vinyl alcohol)-based hydrogels for tissue engineering applications

Synthetic polymers, such as poly(vinyl alcohol) (PVA), are popular biomaterials for the fabrication of hydrogels for tissue engineering and regenerative medicine (TERM) applications, as they provide excellent control over the physico-chemical properties of the hydrogel. However, their bioinert natur...

Full description

Saved in:
Bibliographic Details
Published inBiomaterials science Vol. 12; no. 1; pp. 134 - 15
Main Authors Longoni, Alessia, Major, Gretel S, Jiang, Shaoyuan, Farrugia, Brooke L, Kieser, David C, Woodfield, Tim B. F, Rnjak-Kovacina, Jelena, Lim, Khoon S
Format Journal Article
LanguageEnglish
Published England Royal Society of Chemistry 19.12.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Synthetic polymers, such as poly(vinyl alcohol) (PVA), are popular biomaterials for the fabrication of hydrogels for tissue engineering and regenerative medicine (TERM) applications, as they provide excellent control over the physico-chemical properties of the hydrogel. However, their bioinert nature is known to limit cell-biomaterial interactions by hindering cell infiltration, blood vessel recruitment and potentially limiting their integration with the host tissue. Efforts in the field have therefore focused on increasing the biofunctionality of synthetic hydrogels, without limiting the advantages associated with their tailorability and controlled release capacity. The aim of this study was to investigate the suitability of pristine gelatin to enhance the biofunctionality of tyraminated PVA (PVA-Tyr) hydrogels, by promoting cell infiltration and host blood vessel recruitment for TERM applications. Pure PVA-Tyr hydrogels and PVA-Tyr hydrogels incorporated with vascular endothelial growth factor (VEGF), a well-known pro-angiogenic stimulus, were used for comparison. Incorporating increasing concentrations of VEGF (0.01-10 μg mL −1 ) or gelatin (0.01-5 wt%) did not influence the physical properties of PVA-Tyr hydrogels. However, their presence within the polymer network (>0.1 μg mL −1 VEGF and >0.1 wt% gelatin) promoted endothelial cell interactions with the hydrogels. The covalent binding of unmodified gelatin or VEGF to the PVA-Tyr network did not hamper their inherent bioactivity, as they both promoted angiogenesis in a chick chorioallantoic membrane (CAM) assay, performing comparably with the unbound VEGF control. When the PVA-Tyr hydrogels were implanted subcutaneously in mice, it was observed that cell infiltration into the hydrogels was possible in the absence of gelatin or VEGF at 1- or 3-weeks post-implantation, highlighting a clear difference between in vitro an in vivo cell-biomaterial interaction. Nevertheless, the presence of gelatin or VEGF was necessary to enhance blood vessel recruitment and infiltration, although no significant difference was observed between these two biological molecules. Overall, this study highlights the potential of gelatin as a standalone pro-angiogenic cue to enhance biofunctionality of synthetic hydrogels and provides promise for their use in a variety of TERM applications. In this study, we investigated the suitability of pristine gelatin to enhance the biofunctionality of tyraminated PVA hydrogels, by promoting cell infiltration and host blood vessel recruitment in vitro and in vivo for tissue engineering applications.
AbstractList Synthetic polymers, such as poly(vinyl alcohol) (PVA), are popular biomaterials for the fabrication of hydrogels for tissue engineering and regenerative medicine (TERM) applications, as they provide excellent control over the physico-chemical properties of the hydrogel. However, their bioinert nature is known to limit cell-biomaterial interactions by hindering cell infiltration, blood vessel recruitment and potentially limiting their integration with the host tissue. Efforts in the field have therefore focused on increasing the biofunctionality of synthetic hydrogels, without limiting the advantages associated with their tailorability and controlled release capacity. The aim of this study was to investigate the suitability of pristine gelatin to enhance the biofunctionality of tyraminated PVA (PVA-Tyr) hydrogels, by promoting cell infiltration and host blood vessel recruitment for TERM applications. Pure PVA-Tyr hydrogels and PVA-Tyr hydrogels incorporated with vascular endothelial growth factor (VEGF), a well-known pro-angiogenic stimulus, were used for comparison. Incorporating increasing concentrations of VEGF (0.01–10 μg mL−1) or gelatin (0.01–5 wt%) did not influence the physical properties of PVA-Tyr hydrogels. However, their presence within the polymer network (>0.1 μg mL−1 VEGF and >0.1 wt% gelatin) promoted endothelial cell interactions with the hydrogels. The covalent binding of unmodified gelatin or VEGF to the PVA-Tyr network did not hamper their inherent bioactivity, as they both promoted angiogenesis in a chick chorioallantoic membrane (CAM) assay, performing comparably with the unbound VEGF control. When the PVA-Tyr hydrogels were implanted subcutaneously in mice, it was observed that cell infiltration into the hydrogels was possible in the absence of gelatin or VEGF at 1- or 3-weeks post-implantation, highlighting a clear difference between in vitro an in vivo cell-biomaterial interaction. Nevertheless, the presence of gelatin or VEGF was necessary to enhance blood vessel recruitment and infiltration, although no significant difference was observed between these two biological molecules. Overall, this study highlights the potential of gelatin as a standalone pro-angiogenic cue to enhance biofunctionality of synthetic hydrogels and provides promise for their use in a variety of TERM applications.
Synthetic polymers, such as poly(vinyl alcohol) (PVA), are popular biomaterials for the fabrication of hydrogels for tissue engineering and regenerative medicine (TERM) applications, as they provide excellent control over the physico-chemical properties of the hydrogel. However, their bioinert nature is known to limit cell-biomaterial interactions by hindering cell infiltration, blood vessel recruitment and potentially limiting their integration with the host tissue. Efforts in the field have therefore focused on increasing the biofunctionality of synthetic hydrogels, without limiting the advantages associated with their tailorability and controlled release capacity. The aim of this study was to investigate the suitability of pristine gelatin to enhance the biofunctionality of tyraminated PVA (PVA-Tyr) hydrogels, by promoting cell infiltration and host blood vessel recruitment for TERM applications. Pure PVA-Tyr hydrogels and PVA-Tyr hydrogels incorporated with vascular endothelial growth factor (VEGF), a well-known pro-angiogenic stimulus, were used for comparison. Incorporating increasing concentrations of VEGF (0.01–10 μg mL −1 ) or gelatin (0.01–5 wt%) did not influence the physical properties of PVA-Tyr hydrogels. However, their presence within the polymer network (>0.1 μg mL −1 VEGF and >0.1 wt% gelatin) promoted endothelial cell interactions with the hydrogels. The covalent binding of unmodified gelatin or VEGF to the PVA-Tyr network did not hamper their inherent bioactivity, as they both promoted angiogenesis in a chick chorioallantoic membrane (CAM) assay, performing comparably with the unbound VEGF control. When the PVA-Tyr hydrogels were implanted subcutaneously in mice, it was observed that cell infiltration into the hydrogels was possible in the absence of gelatin or VEGF at 1- or 3-weeks post-implantation, highlighting a clear difference between in vitro an in vivo cell-biomaterial interaction. Nevertheless, the presence of gelatin or VEGF was necessary to enhance blood vessel recruitment and infiltration, although no significant difference was observed between these two biological molecules. Overall, this study highlights the potential of gelatin as a standalone pro-angiogenic cue to enhance biofunctionality of synthetic hydrogels and provides promise for their use in a variety of TERM applications.
Synthetic polymers, such as poly(vinyl alcohol) (PVA), are popular biomaterials for the fabrication of hydrogels for tissue engineering and regenerative medicine (TERM) applications, as they provide excellent control over the physico-chemical properties of the hydrogel. However, their bioinert nature is known to limit cell-biomaterial interactions by hindering cell infiltration, blood vessel recruitment and potentially limiting their integration with the host tissue. Efforts in the field have therefore focused on increasing the biofunctionality of synthetic hydrogels, without limiting the advantages associated with their tailorability and controlled release capacity. The aim of this study was to investigate the suitability of pristine gelatin to enhance the biofunctionality of tyraminated PVA (PVA-Tyr) hydrogels, by promoting cell infiltration and host blood vessel recruitment for TERM applications. Pure PVA-Tyr hydrogels and PVA-Tyr hydrogels incorporated with vascular endothelial growth factor (VEGF), a well-known pro-angiogenic stimulus, were used for comparison. Incorporating increasing concentrations of VEGF (0.01-10 μg mL-1) or gelatin (0.01-5 wt%) did not influence the physical properties of PVA-Tyr hydrogels. However, their presence within the polymer network (>0.1 μg mL-1 VEGF and >0.1 wt% gelatin) promoted endothelial cell interactions with the hydrogels. The covalent binding of unmodified gelatin or VEGF to the PVA-Tyr network did not hamper their inherent bioactivity, as they both promoted angiogenesis in a chick chorioallantoic membrane (CAM) assay, performing comparably with the unbound VEGF control. When the PVA-Tyr hydrogels were implanted subcutaneously in mice, it was observed that cell infiltration into the hydrogels was possible in the absence of gelatin or VEGF at 1- or 3-weeks post-implantation, highlighting a clear difference between in vitro an in vivo cell-biomaterial interaction. Nevertheless, the presence of gelatin or VEGF was necessary to enhance blood vessel recruitment and infiltration, although no significant difference was observed between these two biological molecules. Overall, this study highlights the potential of gelatin as a standalone pro-angiogenic cue to enhance biofunctionality of synthetic hydrogels and provides promise for their use in a variety of TERM applications.
Synthetic polymers, such as poly(vinyl alcohol) (PVA), are popular biomaterials for the fabrication of hydrogels for tissue engineering and regenerative medicine (TERM) applications, as they provide excellent control over the physico-chemical properties of the hydrogel. However, their bioinert nature is known to limit cell-biomaterial interactions by hindering cell infiltration, blood vessel recruitment and potentially limiting their integration with the host tissue. Efforts in the field have therefore focused on increasing the biofunctionality of synthetic hydrogels, without limiting the advantages associated with their tailorability and controlled release capacity. The aim of this study was to investigate the suitability of pristine gelatin to enhance the biofunctionality of tyraminated PVA (PVA-Tyr) hydrogels, by promoting cell infiltration and host blood vessel recruitment for TERM applications. Pure PVA-Tyr hydrogels and PVA-Tyr hydrogels incorporated with vascular endothelial growth factor (VEGF), a well-known pro-angiogenic stimulus, were used for comparison. Incorporating increasing concentrations of VEGF (0.01-10 μg mL −1 ) or gelatin (0.01-5 wt%) did not influence the physical properties of PVA-Tyr hydrogels. However, their presence within the polymer network (>0.1 μg mL −1 VEGF and >0.1 wt% gelatin) promoted endothelial cell interactions with the hydrogels. The covalent binding of unmodified gelatin or VEGF to the PVA-Tyr network did not hamper their inherent bioactivity, as they both promoted angiogenesis in a chick chorioallantoic membrane (CAM) assay, performing comparably with the unbound VEGF control. When the PVA-Tyr hydrogels were implanted subcutaneously in mice, it was observed that cell infiltration into the hydrogels was possible in the absence of gelatin or VEGF at 1- or 3-weeks post-implantation, highlighting a clear difference between in vitro an in vivo cell-biomaterial interaction. Nevertheless, the presence of gelatin or VEGF was necessary to enhance blood vessel recruitment and infiltration, although no significant difference was observed between these two biological molecules. Overall, this study highlights the potential of gelatin as a standalone pro-angiogenic cue to enhance biofunctionality of synthetic hydrogels and provides promise for their use in a variety of TERM applications. In this study, we investigated the suitability of pristine gelatin to enhance the biofunctionality of tyraminated PVA hydrogels, by promoting cell infiltration and host blood vessel recruitment in vitro and in vivo for tissue engineering applications.
Synthetic polymers, such as poly(vinyl alcohol) (PVA), are popular biomaterials for the fabrication of hydrogels for tissue engineering and regenerative medicine (TERM) applications, as they provide excellent control over the physico-chemical properties of the hydrogel. However, their bioinert nature is known to limit cell-biomaterial interactions by hindering cell infiltration, blood vessel recruitment and potentially limiting their integration with the host tissue. Efforts in the field have therefore focused on increasing the biofunctionality of synthetic hydrogels, without limiting the advantages associated with their tailorability and controlled release capacity. The aim of this study was to investigate the suitability of pristine gelatin to enhance the biofunctionality of tyraminated PVA (PVA-Tyr) hydrogels, by promoting cell infiltration and host blood vessel recruitment for TERM applications. Pure PVA-Tyr hydrogels and PVA-Tyr hydrogels incorporated with vascular endothelial growth factor (VEGF), a well-known pro-angiogenic stimulus, were used for comparison. Incorporating increasing concentrations of VEGF (0.01-10 μg mL ) or gelatin (0.01-5 wt%) did not influence the physical properties of PVA-Tyr hydrogels. However, their presence within the polymer network (>0.1 μg mL VEGF and >0.1 wt% gelatin) promoted endothelial cell interactions with the hydrogels. The covalent binding of unmodified gelatin or VEGF to the PVA-Tyr network did not hamper their inherent bioactivity, as they both promoted angiogenesis in a chick chorioallantoic membrane (CAM) assay, performing comparably with the unbound VEGF control. When the PVA-Tyr hydrogels were implanted subcutaneously in mice, it was observed that cell infiltration into the hydrogels was possible in the absence of gelatin or VEGF at 1- or 3-weeks post-implantation, highlighting a clear difference between an cell-biomaterial interaction. Nevertheless, the presence of gelatin or VEGF was necessary to enhance blood vessel recruitment and infiltration, although no significant difference was observed between these two biological molecules. Overall, this study highlights the potential of gelatin as a standalone pro-angiogenic cue to enhance biofunctionality of synthetic hydrogels and provides promise for their use in a variety of TERM applications.
Author Farrugia, Brooke L
Lim, Khoon S
Major, Gretel S
Woodfield, Tim B. F
Longoni, Alessia
Kieser, David C
Rnjak-Kovacina, Jelena
Jiang, Shaoyuan
AuthorAffiliation UNSW Sydney
University of Otago Christchurch
Light-Activated Biomaterials Group
Department of Orthopaedic Surgery and Musculoskeletal Medicine
Graduate School of Biomedical Engineering
University of Melbourne
School of Biomedical Engineering
School of Medical Sciences
University of Sydney
AuthorAffiliation_xml – sequence: 0
  name: University of Otago Christchurch
– sequence: 0
  name: School of Biomedical Engineering
– sequence: 0
  name: University of Melbourne
– sequence: 0
  name: Department of Orthopaedic Surgery and Musculoskeletal Medicine
– sequence: 0
  name: Light-Activated Biomaterials Group
– sequence: 0
  name: Graduate School of Biomedical Engineering
– sequence: 0
  name: UNSW Sydney
– sequence: 0
  name: School of Medical Sciences
– sequence: 0
  name: University of Sydney
Author_xml – sequence: 1
  givenname: Alessia
  surname: Longoni
  fullname: Longoni, Alessia
– sequence: 2
  givenname: Gretel S
  surname: Major
  fullname: Major, Gretel S
– sequence: 3
  givenname: Shaoyuan
  surname: Jiang
  fullname: Jiang, Shaoyuan
– sequence: 4
  givenname: Brooke L
  surname: Farrugia
  fullname: Farrugia, Brooke L
– sequence: 5
  givenname: David C
  surname: Kieser
  fullname: Kieser, David C
– sequence: 6
  givenname: Tim B. F
  surname: Woodfield
  fullname: Woodfield, Tim B. F
– sequence: 7
  givenname: Jelena
  surname: Rnjak-Kovacina
  fullname: Rnjak-Kovacina, Jelena
– sequence: 8
  givenname: Khoon S
  surname: Lim
  fullname: Lim, Khoon S
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37933486$$D View this record in MEDLINE/PubMed
BookMark eNpdkU9v1DAQxS1URNulF-4gS1wKUsCO88c-QktbRBEc4BxNnPGui9dO7QQpn6RfF7dbFgkfxjOan97T6B2TAx88EvKCs3ecCfV-EP2Wcd6Wv56Qo5JVbVHJSh3se8EOyUlKNyy_tlWs4c_IoWiVEJVsjsjd92jTZD3SNTrIDbVehziGmIfgKSQKNE15wvVCp0DRb8BrpNMGaW-Dmb2-B8HZaaHB0DG45fS39Yuj4HTYBPem6CHhQDfLEEN2SdSESCeb0oxZbp3NMVq_pjCOzuoH3_ScPDXgEp48_ivy8-LTj7Or4vrb5eezD9eFFqKdClCDbsqqx1oxANkwpo0GKQE4IJRay7LBesinD1LXJedGKKW0qUCBactWrMjpTneM4XbGNHVbmzQ6Bx7DnLpSykYJVeeyIq__Q2_CHPPlmVJMiLqueZWptztKx5BSRNON0W4hLh1n3X1i3bn4-PUhsS8ZfvUoOfdbHPbo33wy8HIHxKT323-Riz9njaA0
CitedBy_id crossref_primary_10_1002_adhm_202401195
crossref_primary_10_3390_ma17061286
crossref_primary_10_1016_j_cej_2024_150234
crossref_primary_10_1002_mabi_202400049
Cites_doi 10.1016/j.msec.2021.112544
10.1016/j.biomaterials.2013.06.005
10.1016/j.actbio.2021.08.038
10.1039/D1MA00092F
10.1007/s10856-016-5763-9
10.1007/s10439-018-02171-3
10.1016/j.matdes.2021.109652
10.1074/jbc.M609323200
10.1089/ten.tea.2008.0146
10.1073/pnas.1404605111
10.1089/ten.teb.2019.0256
10.1186/s13287-022-03009-5
10.1002/mabi.201000505
10.1039/D0BM00603C
10.22203/eCM.v038a08
10.1016/j.actbio.2017.06.012
10.1007/s13233-022-0027-7
10.1016/j.biomaterials.2013.04.050
10.1021/acs.chemrev.1c00798
10.1038/am.2017.171
10.1016/j.biomaterials.2012.07.057
10.1016/j.actbio.2016.09.006
10.1021/acsabm.9b00275
10.1039/C5TB00939A
10.1021/acsbiomaterials.9b01624
10.3389/fbioe.2020.00188
10.1016/j.actbio.2017.02.044
10.3389/fbioe.2022.849831
10.2147/IJN.S18753
10.1016/j.mvr.2020.104026
10.1016/j.biomaterials.2005.05.036
10.1016/j.actbio.2020.03.005
10.1002/adhm.202100312
10.1016/0741-5214(93)90115-3
10.1016/j.yexcr.2021.112716
10.1016/j.ijpharm.2019.02.043
10.1002/jbm.a.35510
10.1016/j.actbio.2019.07.035
10.1002/advs.202000900
10.1016/j.matdes.2022.110663
10.1002/term.292
10.3390/molecules26040873
10.1016/j.ijbiomac.2022.08.025
10.1002/adhm.202102818
10.1371/journal.pone.0058897
10.1016/j.colsurfb.2019.110756
10.1172/JCI18420
10.1016/j.actbio.2015.08.044
10.1109/TSMC.1979.4310076
10.1096/fj.02-0691fje
10.1038/gt.2011.66
10.1016/j.biomaterials.2020.120104
10.1007/s13346-013-0142-2
10.1016/S0142-9612(00)00196-4
10.1021/acs.bioconjchem.0c00270
10.1016/j.tibtech.2018.01.008
10.1002/sctm.19-0319
10.1371/journal.pbio.3000410
10.1002/term.2957
10.1002/adfm.202210521
10.1016/j.actbio.2012.05.019
10.1021/bm7007907
10.1042/bj0840468
10.1016/j.biomaterials.2018.10.039
10.1021/acsbiomaterials.9b01220
10.1007/s10529-015-1907-0
10.1161/01.CIR.94.5.1074
10.1021/acsabm.0c01648
10.1016/j.biomaterials.2007.08.040
10.1002/adhm.201600058
10.1016/j.actbio.2015.02.024
10.3390/polym12030570
10.1016/j.actbio.2020.01.041
10.1088/2516-1091/abc947
10.1016/j.eurpolymj.2021.110974
10.1016/j.heliyon.2018.e00770
10.1016/j.biomaterials.2011.06.027
10.1016/j.actbio.2014.11.002
10.1038/s41598-017-17204-5
10.1016/j.ijbiomac.2014.09.058
ContentType Journal Article
Copyright Copyright Royal Society of Chemistry 2024
Copyright_xml – notice: Copyright Royal Society of Chemistry 2024
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7SR
8BQ
8FD
JG9
7X8
DOI 10.1039/d3bm01172k
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Engineered Materials Abstracts
METADEX
Technology Research Database
Materials Research Database
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Materials Research Database
Engineered Materials Abstracts
Technology Research Database
METADEX
MEDLINE - Academic
DatabaseTitleList Materials Research Database
CrossRef
MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 2047-4849
EndPage 15
ExternalDocumentID 10_1039_D3BM01172K
37933486
d3bm01172k
Genre Journal Article
GroupedDBID -JG
0-7
0R~
4.4
53G
705
AAEMU
AAHBH
AAIWI
AAJAE
AANOJ
AARTK
AAWGC
AAXHV
ABASK
ABDVN
ABEMK
ABJNI
ABPDG
ABRYZ
ABXOH
ACGFS
ACIWK
ACLDK
ADMRA
ADSRN
AEFDR
AENEX
AENGV
AESAV
AETIL
AFLYV
AFOGI
AFVBQ
AGEGJ
AGRSR
AGSTE
AHGCF
AKBGW
ALMA_UNASSIGNED_HOLDINGS
ANUXI
APEMP
ASKNT
AUDPV
BLAPV
BSQNT
C6K
EBS
ECGLT
EE0
EF-
GGIMP
H13
HZ~
H~N
J3I
O-G
O9-
OK1
RAOCF
RCNCU
RPMJG
RRC
RSCEA
RVUXY
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7SR
8BQ
8FD
JG9
7X8
ID FETCH-LOGICAL-c337t-a9dc624be590aa8600cfca88aa1aea2cc826e5d007d8c5211f3999cf4a9af7273
ISSN 2047-4830
IngestDate Fri Oct 25 04:57:06 EDT 2024
Thu Oct 10 17:07:46 EDT 2024
Fri Dec 06 01:39:08 EST 2024
Sat Nov 02 12:13:03 EDT 2024
Tue Dec 17 20:58:16 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c337t-a9dc624be590aa8600cfca88aa1aea2cc826e5d007d8c5211f3999cf4a9af7273
Notes Electronic supplementary information (ESI) available. See DOI
https://doi.org/10.1039/d3bm01172k
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-5428-7575
0000-0003-1303-4165
0000-0002-2486-196X
0000-0001-6121-4676
PMID 37933486
PQID 2903355514
PQPubID 2047520
PageCount 17
ParticipantIDs crossref_primary_10_1039_D3BM01172K
pubmed_primary_37933486
rsc_primary_d3bm01172k
proquest_journals_2903355514
proquest_miscellaneous_2886939569
PublicationCentury 2000
PublicationDate 2023-12-19
PublicationDateYYYYMMDD 2023-12-19
PublicationDate_xml – month: 12
  year: 2023
  text: 2023-12-19
  day: 19
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Cambridge
PublicationTitle Biomaterials science
PublicationTitleAlternate Biomater Sci
PublicationYear 2023
Publisher Royal Society of Chemistry
Publisher_xml – name: Royal Society of Chemistry
References Wang (D3BM01172K/cit36/1) 2017; 9
Bankhead (D3BM01172K/cit48/1) 2017; 7
Cobbett (D3BM01172K/cit65/1) 1962; 84
Martino (D3BM01172K/cit35/1) 2015; 1
Bello (D3BM01172K/cit37/1) 2020; 26
Atienza-Roca (D3BM01172K/cit41/1) 2020; 8
Lan (D3BM01172K/cit78/1) 2021; 204
Nafea (D3BM01172K/cit12/1) 2015; 103
Hu (D3BM01172K/cit21/1) 2012; 33
Tan (D3BM01172K/cit29/1) 2011; 6
Lim (D3BM01172K/cit42/1) 2015; 15
Lai (D3BM01172K/cit84/1) 2022; 218
Jeong (D3BM01172K/cit52/1) 2022; 30
Mastrullo (D3BM01172K/cit20/1) 2020; 8
Lyu (D3BM01172K/cit67/1) 2021; 26
Sacchi (D3BM01172K/cit26/1) 2014; 111
Koolen (D3BM01172K/cit47/1) 2019; 38
Chiu (D3BM01172K/cit31/1) 2011; 5
Hao (D3BM01172K/cit57/1) 2020; 108
Hutchings (D3BM01172K/cit61/1) 2003; 17
Campillo-Fernández (D3BM01172K/cit55/1) 2008; 15
Unal (D3BM01172K/cit3/1) 2020; 31
Lazarous (D3BM01172K/cit24/1) 1996; 94
Chokoza (D3BM01172K/cit4/1) 2019; 5
Rojek (D3BM01172K/cit85/1) 2022; 122
Anderson (D3BM01172K/cit22/1) 2011; 32
Huang (D3BM01172K/cit58/1) 2005; 26
Abdallah (D3BM01172K/cit74/1) 2017; 54
Van Hoorick (D3BM01172K/cit14/1) 2019; 97
Huettner (D3BM01172K/cit11/1) 2018; 36
Barros (D3BM01172K/cit9/1) 2019; 192
Su (D3BM01172K/cit13/1) 2015; 37
Kim (D3BM01172K/cit75/1) 2020; 188
Ziats (D3BM01172K/cit56/1) 1993; 17
Babavalian (D3BM01172K/cit66/1) 2014; 1
Ribatti (D3BM01172K/cit69/1) 2021; 405
Phelps (D3BM01172K/cit80/1) 2015; 5
Karvinen (D3BM01172K/cit28/1) 2011; 18
Merkle (D3BM01172K/cit51/1) 2015; 27
Bolívar-Monsalve (D3BM01172K/cit2/1) 2021; 2
Marchioli (D3BM01172K/cit19/1) 2016; 5
Chapla (D3BM01172K/cit8/1) 2021; 3
Mori da Cunha (D3BM01172K/cit5/1) 2020; 106
Cerroni (D3BM01172K/cit76/1) 2018; 4
Dreesmann (D3BM01172K/cit38/1) 2007; 28
Davidenko (D3BM01172K/cit82/1) 2016; 27
Percie du Sert (D3BM01172K/cit45/1) 2020; 18
Vlahakis (D3BM01172K/cit60/1) 2007; 282
Xu (D3BM01172K/cit1/1) 2022; 10
Fu (D3BM01172K/cit34/1) 2017; 58
Byzova (D3BM01172K/cit63/1) 2000; 6
Ozawa (D3BM01172K/cit27/1) 2004; 113
Jia (D3BM01172K/cit10/1) 2016; 45
Saotome (D3BM01172K/cit54/1) 2015; 3
Echave (D3BM01172K/cit18/1) 2019; 562
Guerrero (D3BM01172K/cit64/1) 2020; 12
Ramadhan (D3BM01172K/cit50/1) 2019; 2
Mann (D3BM01172K/cit33/1) 2001; 22
Mony (D3BM01172K/cit40/1) 2021; 4
Tang (D3BM01172K/cit72/1) 2022; 11
Zhang (D3BM01172K/cit15/1) 2022; 219
Adelnia (D3BM01172K/cit73/1) 2022; 164
Oliviero (D3BM01172K/cit71/1) 2012; 8
Otsu (D3BM01172K/cit44/1) 1979; 9
Ma (D3BM01172K/cit83/1) 2022; 13
Soliman (D3BM01172K/cit46/1) 2023; 33
Monchaux (D3BM01172K/cit53/1) 2007; 8
Chuang (D3BM01172K/cit79/1) 2015; 19
Turturro (D3BM01172K/cit77/1) 2013; 8
Lim (D3BM01172K/cit17/1) 2013; 34
Qaum (D3BM01172K/cit30/1) 2001; 42
Kopeć (D3BM01172K/cit16/1) 2022; 134
Traub (D3BM01172K/cit62/1) 2013; 34
Li (D3BM01172K/cit70/1) 2015; 13
Ribatti (D3BM01172K/cit68/1) 2020; 131
Shalumon (D3BM01172K/cit49/1) 2015; 72
Tang (D3BM01172K/cit81/1) 2020; 6
Masters (D3BM01172K/cit32/1) 2011; 11
Wang (D3BM01172K/cit39/1) 2022; 11
Trujillo (D3BM01172K/cit7/1) 2020; 252
Post (D3BM01172K/cit59/1) 2019; 47
Gianni-Barrera (D3BM01172K/cit25/1) 2020; 9
Lin (D3BM01172K/cit43/1) 2020; 7
Wang (D3BM01172K/cit6/1) 2021; 135
Mizuno (D3BM01172K/cit23/1) 2019; 13
References_xml – volume: 134
  start-page: 112544
  year: 2022
  ident: D3BM01172K/cit16/1
  publication-title: Biomater. Adv.
  doi: 10.1016/j.msec.2021.112544
  contributor:
    fullname: Kopeć
– volume: 34
  start-page: 7097
  year: 2013
  ident: D3BM01172K/cit17/1
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2013.06.005
  contributor:
    fullname: Lim
– volume: 135
  start-page: 260
  year: 2021
  ident: D3BM01172K/cit6/1
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2021.08.038
  contributor:
    fullname: Wang
– volume: 2
  start-page: 4447
  year: 2021
  ident: D3BM01172K/cit2/1
  publication-title: Mater. Adv.
  doi: 10.1039/D1MA00092F
  contributor:
    fullname: Bolívar-Monsalve
– volume: 27
  start-page: 148
  year: 2016
  ident: D3BM01172K/cit82/1
  publication-title: J. Mater. Sci. Mater. Med.
  doi: 10.1007/s10856-016-5763-9
  contributor:
    fullname: Davidenko
– volume: 47
  start-page: 366
  year: 2019
  ident: D3BM01172K/cit59/1
  publication-title: Ann. Biomed. Eng.
  doi: 10.1007/s10439-018-02171-3
  contributor:
    fullname: Post
– volume: 204
  start-page: 109652
  year: 2021
  ident: D3BM01172K/cit78/1
  publication-title: Mater. Des.
  doi: 10.1016/j.matdes.2021.109652
  contributor:
    fullname: Lan
– volume: 282
  start-page: 15187
  year: 2007
  ident: D3BM01172K/cit60/1
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M609323200
  contributor:
    fullname: Vlahakis
– volume: 15
  start-page: 1331
  year: 2008
  ident: D3BM01172K/cit55/1
  publication-title: Tissue Eng., Part A
  doi: 10.1089/ten.tea.2008.0146
  contributor:
    fullname: Campillo-Fernández
– volume: 111
  start-page: 6952
  year: 2014
  ident: D3BM01172K/cit26/1
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1404605111
  contributor:
    fullname: Sacchi
– volume: 26
  start-page: 164
  year: 2020
  ident: D3BM01172K/cit37/1
  publication-title: Tissue Eng., Part B
  doi: 10.1089/ten.teb.2019.0256
  contributor:
    fullname: Bello
– volume: 13
  start-page: 327
  year: 2022
  ident: D3BM01172K/cit83/1
  publication-title: Stem Cell Res. Ther.
  doi: 10.1186/s13287-022-03009-5
  contributor:
    fullname: Ma
– volume: 11
  start-page: 1149
  year: 2011
  ident: D3BM01172K/cit32/1
  publication-title: Macromol. Biosci.
  doi: 10.1002/mabi.201000505
  contributor:
    fullname: Masters
– volume: 8
  start-page: 5005
  year: 2020
  ident: D3BM01172K/cit41/1
  publication-title: Biomater. Sci.
  doi: 10.1039/D0BM00603C
  contributor:
    fullname: Atienza-Roca
– volume: 38
  start-page: 94
  year: 2019
  ident: D3BM01172K/cit47/1
  publication-title: Eur. Cells Mater.
  doi: 10.22203/eCM.v038a08
  contributor:
    fullname: Koolen
– volume: 58
  start-page: 225
  year: 2017
  ident: D3BM01172K/cit34/1
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2017.06.012
  contributor:
    fullname: Fu
– volume: 30
  start-page: 223
  year: 2022
  ident: D3BM01172K/cit52/1
  publication-title: Macromol. Res.
  doi: 10.1007/s13233-022-0027-7
  contributor:
    fullname: Jeong
– volume: 34
  start-page: 5958
  year: 2013
  ident: D3BM01172K/cit62/1
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2013.04.050
  contributor:
    fullname: Traub
– volume: 122
  start-page: 16839
  year: 2022
  ident: D3BM01172K/cit85/1
  publication-title: Chem. Rev.
  doi: 10.1021/acs.chemrev.1c00798
  contributor:
    fullname: Rojek
– volume: 9
  start-page: e435
  year: 2017
  ident: D3BM01172K/cit36/1
  publication-title: NPG Asia Mater.
  doi: 10.1038/am.2017.171
  contributor:
    fullname: Wang
– volume: 33
  start-page: 8082
  year: 2012
  ident: D3BM01172K/cit21/1
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2012.07.057
  contributor:
    fullname: Hu
– volume: 45
  start-page: 110
  year: 2016
  ident: D3BM01172K/cit10/1
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2016.09.006
  contributor:
    fullname: Jia
– volume: 2
  start-page: 2600
  year: 2019
  ident: D3BM01172K/cit50/1
  publication-title: ACS Appl. Bio Mater.
  doi: 10.1021/acsabm.9b00275
  contributor:
    fullname: Ramadhan
– volume: 3
  start-page: 7109
  year: 2015
  ident: D3BM01172K/cit54/1
  publication-title: J. Mater. Chem. B
  doi: 10.1039/C5TB00939A
  contributor:
    fullname: Saotome
– volume: 6
  start-page: 1476
  year: 2020
  ident: D3BM01172K/cit81/1
  publication-title: ACS Biomater. Sci. Eng.
  doi: 10.1021/acsbiomaterials.9b01624
  contributor:
    fullname: Tang
– volume: 8
  start-page: 188
  year: 2020
  ident: D3BM01172K/cit20/1
  publication-title: Front. Bioeng. Biotechnol.
  doi: 10.3389/fbioe.2020.00188
  contributor:
    fullname: Mastrullo
– volume: 54
  start-page: 150
  year: 2017
  ident: D3BM01172K/cit74/1
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2017.02.044
  contributor:
    fullname: Abdallah
– volume: 10
  start-page: 849831
  year: 2022
  ident: D3BM01172K/cit1/1
  publication-title: Front. Bioeng. Biotechnol.
  doi: 10.3389/fbioe.2022.849831
  contributor:
    fullname: Xu
– volume: 6
  start-page: 929
  year: 2011
  ident: D3BM01172K/cit29/1
  publication-title: Int. J. Nanomed.
  doi: 10.2147/IJN.S18753
  contributor:
    fullname: Tan
– volume: 131
  start-page: 104026
  year: 2020
  ident: D3BM01172K/cit68/1
  publication-title: Microvasc. Res.
  doi: 10.1016/j.mvr.2020.104026
  contributor:
    fullname: Ribatti
– volume: 26
  start-page: 7616
  year: 2005
  ident: D3BM01172K/cit58/1
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2005.05.036
  contributor:
    fullname: Huang
– volume: 108
  start-page: 178
  year: 2020
  ident: D3BM01172K/cit57/1
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2020.03.005
  contributor:
    fullname: Hao
– volume: 6
  start-page: 851
  year: 2000
  ident: D3BM01172K/cit63/1
  publication-title: Mol. Cell
  contributor:
    fullname: Byzova
– volume: 1
  start-page: 83
  year: 2014
  ident: D3BM01172K/cit66/1
  publication-title: J. Appl. Biotechnol. Rep.
  contributor:
    fullname: Babavalian
– volume: 11
  start-page: 2100312
  year: 2022
  ident: D3BM01172K/cit72/1
  publication-title: Adv. Healthcare Mater.
  doi: 10.1002/adhm.202100312
  contributor:
    fullname: Tang
– volume: 17
  start-page: 710
  year: 1993
  ident: D3BM01172K/cit56/1
  publication-title: J. Vasc. Surg.
  doi: 10.1016/0741-5214(93)90115-3
  contributor:
    fullname: Ziats
– volume: 405
  start-page: 112716
  year: 2021
  ident: D3BM01172K/cit69/1
  publication-title: Exp. Cell Res.
  doi: 10.1016/j.yexcr.2021.112716
  contributor:
    fullname: Ribatti
– volume: 15
  start-page: 1423
  issue: 10
  year: 2015
  ident: D3BM01172K/cit42/1
  publication-title: Cham
  contributor:
    fullname: Lim
– volume: 562
  start-page: 151
  year: 2019
  ident: D3BM01172K/cit18/1
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2019.02.043
  contributor:
    fullname: Echave
– volume: 103
  start-page: 3727
  year: 2015
  ident: D3BM01172K/cit12/1
  publication-title: J. Biomed. Mater. Res., Part A
  doi: 10.1002/jbm.a.35510
  contributor:
    fullname: Nafea
– volume: 97
  start-page: 46
  year: 2019
  ident: D3BM01172K/cit14/1
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2019.07.035
  contributor:
    fullname: Van Hoorick
– volume: 7
  start-page: 2000900
  year: 2020
  ident: D3BM01172K/cit43/1
  publication-title: Adv. Sci.
  doi: 10.1002/advs.202000900
  contributor:
    fullname: Lin
– volume: 218
  start-page: 110663
  year: 2022
  ident: D3BM01172K/cit84/1
  publication-title: Mater. Des.
  doi: 10.1016/j.matdes.2022.110663
  contributor:
    fullname: Lai
– volume: 5
  start-page: 69
  year: 2011
  ident: D3BM01172K/cit31/1
  publication-title: J. Tissue Eng. Regener. Med.
  doi: 10.1002/term.292
  contributor:
    fullname: Chiu
– volume: 26
  start-page: 873
  issue: 4
  year: 2021
  ident: D3BM01172K/cit67/1
  publication-title: Molecules
  doi: 10.3390/molecules26040873
  contributor:
    fullname: Lyu
– volume: 219
  start-page: 672
  year: 2022
  ident: D3BM01172K/cit15/1
  publication-title: Int. J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2022.08.025
  contributor:
    fullname: Zhang
– volume: 11
  start-page: 2102818
  year: 2022
  ident: D3BM01172K/cit39/1
  publication-title: Adv. Healthcare Mater.
  doi: 10.1002/adhm.202102818
  contributor:
    fullname: Wang
– volume: 8
  start-page: e58897
  year: 2013
  ident: D3BM01172K/cit77/1
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0058897
  contributor:
    fullname: Turturro
– volume: 188
  start-page: 110756
  year: 2020
  ident: D3BM01172K/cit75/1
  publication-title: Colloids Surf., B
  doi: 10.1016/j.colsurfb.2019.110756
  contributor:
    fullname: Kim
– volume: 113
  start-page: 516
  year: 2004
  ident: D3BM01172K/cit27/1
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI18420
  contributor:
    fullname: Ozawa
– volume: 27
  start-page: 77
  year: 2015
  ident: D3BM01172K/cit51/1
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2015.08.044
  contributor:
    fullname: Merkle
– volume: 9
  start-page: 62
  year: 1979
  ident: D3BM01172K/cit44/1
  publication-title: IEEE Trans. Syst., Man, Cyber.
  doi: 10.1109/TSMC.1979.4310076
  contributor:
    fullname: Otsu
– volume: 17
  start-page: 1520
  year: 2003
  ident: D3BM01172K/cit61/1
  publication-title: FASEB J.
  doi: 10.1096/fj.02-0691fje
  contributor:
    fullname: Hutchings
– volume: 42
  start-page: 2408
  year: 2001
  ident: D3BM01172K/cit30/1
  publication-title: Invest. Ophthalmol. Visual Sci.
  contributor:
    fullname: Qaum
– volume: 18
  start-page: 1166
  year: 2011
  ident: D3BM01172K/cit28/1
  publication-title: Gene Ther.
  doi: 10.1038/gt.2011.66
  contributor:
    fullname: Karvinen
– volume: 252
  start-page: 120104
  year: 2020
  ident: D3BM01172K/cit7/1
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2020.120104
  contributor:
    fullname: Trujillo
– volume: 5
  start-page: 125
  year: 2015
  ident: D3BM01172K/cit80/1
  publication-title: Drug Delivery Transl. Res.
  doi: 10.1007/s13346-013-0142-2
  contributor:
    fullname: Phelps
– volume: 22
  start-page: 439
  year: 2001
  ident: D3BM01172K/cit33/1
  publication-title: Biomaterials
  doi: 10.1016/S0142-9612(00)00196-4
  contributor:
    fullname: Mann
– volume: 31
  start-page: 2253
  year: 2020
  ident: D3BM01172K/cit3/1
  publication-title: Bioconjugate Chem.
  doi: 10.1021/acs.bioconjchem.0c00270
  contributor:
    fullname: Unal
– volume: 36
  start-page: 372
  year: 2018
  ident: D3BM01172K/cit11/1
  publication-title: Trends Biotechnol.
  doi: 10.1016/j.tibtech.2018.01.008
  contributor:
    fullname: Huettner
– volume: 9
  start-page: 433
  year: 2020
  ident: D3BM01172K/cit25/1
  publication-title: Stem Cells Transl. Med.
  doi: 10.1002/sctm.19-0319
  contributor:
    fullname: Gianni-Barrera
– volume: 18
  start-page: e3000410
  year: 2020
  ident: D3BM01172K/cit45/1
  publication-title: PLos Biol.
  doi: 10.1371/journal.pbio.3000410
  contributor:
    fullname: Percie du Sert
– volume: 13
  start-page: 2291
  year: 2019
  ident: D3BM01172K/cit23/1
  publication-title: J. Tissue Eng. Regener. Med.
  doi: 10.1002/term.2957
  contributor:
    fullname: Mizuno
– volume: 33
  start-page: 2210521
  year: 2023
  ident: D3BM01172K/cit46/1
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.202210521
  contributor:
    fullname: Soliman
– volume: 8
  start-page: 3294
  year: 2012
  ident: D3BM01172K/cit71/1
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2012.05.019
  contributor:
    fullname: Oliviero
– volume: 8
  start-page: 3668
  year: 2007
  ident: D3BM01172K/cit53/1
  publication-title: Biomacromolecules
  doi: 10.1021/bm7007907
  contributor:
    fullname: Monchaux
– volume: 84
  start-page: 468
  year: 1962
  ident: D3BM01172K/cit65/1
  publication-title: Biochem. J.
  doi: 10.1042/bj0840468
  contributor:
    fullname: Cobbett
– volume: 1
  start-page: 3
  year: 2015
  ident: D3BM01172K/cit35/1
  publication-title: Front. Bioeng. Biotechnol.
  contributor:
    fullname: Martino
– volume: 192
  start-page: 601
  year: 2019
  ident: D3BM01172K/cit9/1
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2018.10.039
  contributor:
    fullname: Barros
– volume: 5
  start-page: 5430
  year: 2019
  ident: D3BM01172K/cit4/1
  publication-title: ACS Biomater. Sci. Eng.
  doi: 10.1021/acsbiomaterials.9b01220
  contributor:
    fullname: Chokoza
– volume: 37
  start-page: 2139
  year: 2015
  ident: D3BM01172K/cit13/1
  publication-title: Biotechnol. Lett.
  doi: 10.1007/s10529-015-1907-0
  contributor:
    fullname: Su
– volume: 94
  start-page: 1074
  year: 1996
  ident: D3BM01172K/cit24/1
  publication-title: Circulation
  doi: 10.1161/01.CIR.94.5.1074
  contributor:
    fullname: Lazarous
– volume: 4
  start-page: 3320
  year: 2021
  ident: D3BM01172K/cit40/1
  publication-title: ACS Appl. Bio Mater.
  doi: 10.1021/acsabm.0c01648
  contributor:
    fullname: Mony
– volume: 28
  start-page: 5536
  year: 2007
  ident: D3BM01172K/cit38/1
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2007.08.040
  contributor:
    fullname: Dreesmann
– volume: 5
  start-page: 1606
  year: 2016
  ident: D3BM01172K/cit19/1
  publication-title: Adv. Healthcare Mater.
  doi: 10.1002/adhm.201600058
  contributor:
    fullname: Marchioli
– volume: 19
  start-page: 85
  year: 2015
  ident: D3BM01172K/cit79/1
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2015.02.024
  contributor:
    fullname: Chuang
– volume: 12
  start-page: 570
  year: 2020
  ident: D3BM01172K/cit64/1
  publication-title: Polymers
  doi: 10.3390/polym12030570
  contributor:
    fullname: Guerrero
– volume: 106
  start-page: 82
  year: 2020
  ident: D3BM01172K/cit5/1
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2020.01.041
  contributor:
    fullname: Mori da Cunha
– volume: 3
  start-page: 012002
  year: 2021
  ident: D3BM01172K/cit8/1
  publication-title: Prog. Biomed. Eng.
  doi: 10.1088/2516-1091/abc947
  contributor:
    fullname: Chapla
– volume: 164
  start-page: 110974
  year: 2022
  ident: D3BM01172K/cit73/1
  publication-title: Eur. Polym. J.
  doi: 10.1016/j.eurpolymj.2021.110974
  contributor:
    fullname: Adelnia
– volume: 4
  start-page: e00770
  year: 2018
  ident: D3BM01172K/cit76/1
  publication-title: Heliyon
  doi: 10.1016/j.heliyon.2018.e00770
  contributor:
    fullname: Cerroni
– volume: 32
  start-page: 7432
  year: 2011
  ident: D3BM01172K/cit22/1
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2011.06.027
  contributor:
    fullname: Anderson
– volume: 13
  start-page: 88
  year: 2015
  ident: D3BM01172K/cit70/1
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2014.11.002
  contributor:
    fullname: Li
– volume: 7
  start-page: 16878
  year: 2017
  ident: D3BM01172K/cit48/1
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-17204-5
  contributor:
    fullname: Bankhead
– volume: 72
  start-page: 1048
  year: 2015
  ident: D3BM01172K/cit49/1
  publication-title: Int. J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2014.09.058
  contributor:
    fullname: Shalumon
SSID ssj0000779061
Score 2.3852706
Snippet Synthetic polymers, such as poly(vinyl alcohol) (PVA), are popular biomaterials for the fabrication of hydrogels for tissue engineering and regenerative...
SourceID proquest
crossref
pubmed
rsc
SourceType Aggregation Database
Index Database
Publisher
StartPage 134
SubjectTerms Animals
Biocompatible Materials - chemistry
Biocompatible Materials - pharmacology
Biomedical materials
Blood vessels
Chemical properties
Constraining
Controlled release
Endothelial cells
Ethanol
Gelatin
Gelatin - chemistry
Growth factors
Hydrogels
Hydrogels - chemistry
Infiltration
Mice
Physical properties
Polymers - chemistry
Polyvinyl alcohol
Polyvinyl Alcohol - chemistry
Surgical implants
Tissue Engineering
Vascular endothelial growth factor
Vascular Endothelial Growth Factor A
Title Pristine gelatin incorporation as a strategy to enhance the biofunctionality of poly(vinyl alcohol)-based hydrogels for tissue engineering applications
URI https://www.ncbi.nlm.nih.gov/pubmed/37933486
https://www.proquest.com/docview/2903355514
https://search.proquest.com/docview/2886939569
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZK9wIPiNugMJARIIGilMZOsvhxg8GAFSHRSXurHMe9cEmmXpDKH-Ef8bs4x3bcdOVh8BJVbmu3OV_O-Wwff4eQpzKKFVbSDjXLRRjHOQ9zpZMQSxXCfCJXCcOzw_2P6fFp_P4sOWu1fjeylpaLvKt-_vVcyf9YFdrArnhK9h8s6zuFBngN9oUrWBiul7LxJ_OEAk0cm5Q2TFpUTpnYZBnPAxnMrfysIZm6nJgTAkg282mFMc0uBbq8jPMK605nP6blChOXTfHcZ0yEGOqKYLIqZhWMNLepicZi0KXXMwyam-Ebm8XTCnixvSGBC7k-Eagqx5UpK4VnbeAB9WGiL7_YpYS3MyD234LPXZ_tM60XuSeyWi3X-EZFyeXYpv8ezlBMNDjpNtc1GMccEec9jftjqCERZ27XRjfbrMip999sC6fWGUdumdTG9cgK3G6FjB5HxdXX_LCP8njswzow1skAF-Klz2I0-_dcDNffvUJ2UJAxbpOdg6PBuxO_2tdDWUcj3uv_Vq2Vy8XLdQeb7GhrygMEaFYXpjEEaHCDXHczF3pgYXiTtHR5i1xr6FneJr9qQFIHSLoBSCrnVNIakHRRUQdICoCkFwFJqxFFQD43cKQOji8sGKkHIwUwUgtG2gAjbYLxDjl9czR4dRy6yh-h4nx_EUpRqJTFuU5ET8oMSLkaKZllUkZSS6YUTIp1UsBtLTLwJlE0Ap4t1CiWQo6Qke-SdlmV-h6hrNAyilSaxVrHKIOri32JddcYdKUy1SFP6js-PLcCL8Ntw3bIXm2MoXMA8yETPQ50HaYcHfLYvw3uGffcZKmrJXwmy1LBRZKKDrlrjeiH4RAbeZylHbILVvXNBc-_m1G_3r_Ub3tArq6fnz3SXsyW-iEw5UX-yMHwD9T8xY0
link.rule.ids 314,780,784,27924,27925
linkProvider Royal Society of Chemistry
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pristine+gelatin+incorporation+as+a+strategy+to+enhance+the+biofunctionality+of+poly%28vinyl+alcohol%29-based+hydrogels+for+tissue+engineering+applications&rft.jtitle=Biomaterials+science&rft.au=Longoni%2C+Alessia&rft.au=Major%2C+Gretel+S.&rft.au=Jiang%2C+Shaoyuan&rft.au=Farrugia%2C+Brooke+L.&rft.date=2023-12-19&rft.issn=2047-4830&rft.eissn=2047-4849&rft.volume=12&rft.issue=1&rft.spage=134&rft.epage=150&rft_id=info:doi/10.1039%2FD3BM01172K&rft.externalDBID=n%2Fa&rft.externalDocID=10_1039_D3BM01172K
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2047-4830&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2047-4830&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2047-4830&client=summon